![imisophia Profile](https://pbs.twimg.com/profile_images/1250365546396299264/P8bwDkWW_x96.png)
imisophia
@imisophia
Followers
337
Following
143
Statuses
207
Joined April 2020
Congrats to @francois_pattou and team for their research identifying two distinct subtypes of MASLD – liver-specific and cardiometabolic – each with distinct risk profiles📢 find out more in @NatureMedicine
Excited to share our latest study with @stefano_romeo76 , published in @NatureMedicine! We uncover 2 distinct subtypes of MASH: 🔹 Liver-specific: Faster liver disease progression, lower CV risk. 🔹 Cardiometabolic: Higher CV/metabolic risks, incl. T2D.
0
0
2
Congrats to SOPHIA PhD fellow Lucas Schreurs 🌠 who won an award for Best New Investigator Poster Research Presentation at 2024 ISPOR in Barcelona 🏆 see it here and stay tuned for our SOPHIA Blueprint for Change report, coming soon! @Third_i_eu
0
1
3
RT @AbdTahrani: Phentyping #obesity has always been challenging. In this very interesting paper @NatureMedicine , the @imisophia team iden…
0
11
0
"For me, as a clinician, that's going to change how I treat patients" 👨⚕️🩺 Dr. @carel_leroux from @ucddublin talks about how we're working to find the predictors of risk and response for those living with #obesity - and how this impacts patient care.
0
3
6
What influences patient decisions when selecting an obesity treatment? by @Dardhill, David Wally, and Prof @carel_leroux
0
0
2
“What would be left of me?” Patient perspectives on the risks of obesity treatment: An @imisophia qualitative study by @emmaefarrell @JNadglowskiOAC @EvaHollmann @carel_leroux and @Deemcgillicuddy
0
2
4
"The right tool at the right moment" - @francois_pattou from @CHU_Lille discusses how our SOPHIA federated database gives him the power to securely combine and analyse patient data with scientists and data sources across Europe 🌍🖥️ Find out more here
0
1
4
"A complex lived experience" - @Deemcgillicuddy speaks with @werdalnajim from @ucddublin about the importance of the patient experience in obesity research and how this helps us improve obesity care 💚 Find out more here
0
2
5
Important work from SOPHIA partner @EASOobesity 👏
Professor @busetto_lucao responds to the new EASO publication in @NatureMedicine on a framework for diagnosing, staging, and managing obesity in adults. ➡️ The need for a clinical approach that goes beyond BMI.
0
0
1
🚨 New Study Alert! 🚨 “Patient perspectives on personalised medicine for obesity: An IMI2 project” highlights the importance of patient involvement in developing obesity treatments @emmaefarrell @carel_leroux @JNadglowskiOAC @Deemcgillicuddy @EvaHollmann
0
1
3
Prof @carel_leroux remarked that patients are generally very optimistic about the potential for personalised obesity medicine but also raise a number of legitimate concerns that will be of interest to clinicians, industry, and policy makers @IHIEurope
0
1
4
Congrats to a successful SOPHIA symposium at #ICO2024 💥 @carel_leroux, Miroslava Guadjardo, Ebaa Al Ozairi, @werdalnajim and Elena Startseva represented the entire SOPHIA consortium at our symposium in Sao Paulo, Brazil 🇧🇷🌎
0
2
3
LIVE from #ICO2024 🎥"We had to redefine how we think about obesity" SOPHIA coordinator @carel_leroux from @ucddublin speaks about our transformative research in the field of #obesity care at the ICO SOPHIA symposium in Sao Paulo, Brazil 🇧🇷
0
1
2
Great work by SOPHIA partner @EASO on how to use first person language to address weight bias in #obesity research and healthcare 💚
Check our our First Person Language Guide: Addressing Weight Bias This guide aims to support the development of non-stigmatising research, project outputs and other communications. Thanks to @xramossalas! Download here:
0
3
5
Join us at the SOPHIA symposium at #ICO2024, Sao Paulo, Brazil, Wed 26, 10-11:30 in Room 4 📣as @carel_leroux (@ucddublin) Ebaa Al Ozairi (@dasmaninstitute) and @werdalnajim (@ucddublin ) present our SOPHIA research and how we're working together to improve obesity care 💚
0
1
4
Our new website is here! ✨ New look, same objective - a new future for #obesity care 💚 Check out the website to explore our partners, goals and our published results here:
0
3
6